Astellas Launches Kiklin Capsules, Copromotes with SKK

June 26, 2012
Astellas Pharma launched on June 26 its hyperphosphatemia treatment Kiklin Capsules 250mg (bixalomar). The NHI price for the drug is 29.70 yen per capsule, and peak sales are expected to be 7 billion yen in FY2016 on an NHI price...read more